Biomarkers and Sepsis: New Tools May Aid Early Diagnosis and Treatment
Thank you for your interest in our AACC Workshop "Biomarkers and Sepsis: New Tools May Aid Early Diagnosis and Treatment"
Summary: Sepsis is a leading cause of death worldwide, with bacterial infection accounting for the majority of cases. Progression from a systemic inflammatory response to septic shock is associated with increased mortality and can occur rapidly. The often nonspecific nature of symptoms can confound an early diagnosis and may delay critical intervention. Biomarkers such as procalcitonin may aid in early identification and support the decision to treat. This workshop discusses the growing burden of sepsis and reviews evidence for the potential role of biomarkers, as well as bacterial identification and resistance testing in the diagnosis and treatment of sepsis.
- Dr. Timothy G. Buchman, Ph.D., M.D., FACS, FCCM
Director, Emory Center for Critical Care
- Dr. Eric H. Gluck, M.D.
Director, Critical Care Services
Swedish Covenant Hospital
- Dr. Joseph Campos, Ph.D., D(ABMM), F(AAM)
Director, Microbiology Laboratory, Molecular Diagnostics Laboratory and Laboratory Informatics, Children’s National Medical Center
Professor, Departments of Pediatrics, Pathology, and Microbiology/Immunology/Tropical Medicine
George Washington University Medical Center Washington, D. C.
After completion of the following form, you will receive a confirmation email which will include a link to the workshop video.
Aufgrund von Wartungsarbeiten ist diese Seite nicht verfügbar.
Bitte versuchen Sie es später noch einmal.